Infectious complications and conservative treatment of totally implantable venous access devices in children with cancer

被引:1
|
作者
Yazici, Nalan [1 ]
Akyuz, Canan [2 ]
Yalcin, Bilgehan [2 ]
Varan, Ali [2 ]
Kutluk, Tezer [2 ]
Buyukpamukcu, Munevver [2 ]
机构
[1] Baskent Univ, Dept Pediat Oncol, Adana Med & Res Ctr, Fac Med, Adana, Turkey
[2] Hacettepe Univ, Inst Oncol, Dept Pediat Oncol, Ankara, Turkey
关键词
totally implantable venous access devices; infection; pediatric cancer; LONG-TERM CHEMOTHERAPY; HICKMAN CATHETERS; FOLLOW-UP; PORTS; MANAGEMENT; PREVENTION; BLOOD; TRIAL; RATES;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Besides their complications, totally implantable venous access devices (TIVADs) increase the quality of life in children with cancer. The aim of this study was analysis of infectious complications and results of conservative management in TIVADs. Three hundred and one catheters were implanted in 283 patients between February 1991 and January 2005. Infectious complications were analyzed retrospectively. Cumulative duration of implantation was 153,757 days. In 140 devices (46.5%), no complication was detected. Total rate of infection was 1.96/1000 catheter days. Types of infections were as follows: catheter-related bloodstream infections: 190; catheter-related systemic infections: 74; pocket infections: 19, exit site infections: 14; and tunnel infections: 5. Staphylococcus epidermidis and non-albicans candida were the most common isolations. During follow-up, a total of 119 catheters had been removed. Most of them were due to infection (n=42). In conclusion, TIVADs are important in children with cancer who need prolonged intravenous access, so they should be used carefully and managed conservatively in case of complications.
引用
收藏
页码:164 / 171
页数:8
相关论文
共 50 条
  • [21] Exploring risk factors for totally implantable venous access devices (TIVADs)-related thrombotic occlusion in the off-treatment period
    Liu, Lei
    Liu, Zhanlun
    Wang, Jianxin
    Cheng, Meng
    Xie, Yanli
    Wang, Weina
    Ma, Cuicui
    Zhang, Lina
    Song, Zhenchuan
    Zhang, Yanshou
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [22] Totally implantable venous access ports: Retrospective review of long-term complications in 81 patients
    Bassi, K. K.
    Giri, A. K.
    Pattanayak, M.
    Abraham, S. W.
    Pandey, K. K.
    INDIAN JOURNAL OF CANCER, 2012, 49 (01) : 114 - 118
  • [23] Late complications associated with totally implantable venous access port implantation via the internal jugular vein
    Tsuruta, Shigeaki
    Goto, Yasutomo
    Miyake, Hideo
    Nagai, Hidemasa
    Yoshioka, Yuichiro
    Yuasa, Norihiro
    Takamizawa, Junichi
    SUPPORTIVE CARE IN CANCER, 2020, 28 (06) : 2761 - 2768
  • [24] Catheter-related Complications of Subcutaneous Implantable Venous Access Devices in Breast Cancer Patients
    El-Balat, Ahmed
    Schmeil, Iryna
    Karn, Thomas
    Holtrich, Uwe
    Mavrova-Risteska, Loreta
    Rody, Achim
    Youssef, Aly
    Hanker, Lars C.
    IN VIVO, 2018, 32 (05): : 1275 - 1281
  • [25] Explantation of totally implantable venous access ports of the forearm: reasons for removal and observed complications
    Goltz, Jan P.
    Kickuth, Ralph
    Scholl, Anne
    Machann, Wolfram
    Ritter, Christian O.
    Hahn, Dietbert
    Wittenberg, Guenther
    JOURNAL OF VASCULAR ACCESS, 2011, 12 (01) : 45 - 51
  • [26] Could antibiotic prophylaxis be not necessary to implant totally implantable venous access devices? Randomized prospective study
    Di Carlo, Isidoro
    Toro, Adriana
    Pulvirenti, Elia
    Palermo, Filippo
    Scibilia, Giuseppe
    Cordio, Stefano
    SURGICAL ONCOLOGY-OXFORD, 2011, 20 (01): : 20 - 25
  • [27] Risk Factors for Totally Implantable Central Venous Access Port-related Infection in Patients With Malignancy
    Furuhashi, Satoru
    Morita, Yoshifumi
    Ida, Shinya
    Muraki, Ryuta
    Kitajima, Ryo
    Suzuki, Katsunori
    Takeda, Makoto
    Kikuchi, Hirotoshi
    Hiramatsu, Yoshihiro
    Kurachi, Kiyotaka
    Shido, Yoji
    Sugimoto, Ken
    Ito, Hiroaki
    Maekawa, Yuichiro
    Mineta, Hiroyuki
    Miyake, Hideaki
    Takeuchi, Hiroya
    ANTICANCER RESEARCH, 2021, 41 (03) : 1547 - 1553
  • [28] Complications associated with the removal of totally implantable venous access devices (TIVADs): a retrospective analysis of 4,954 breast cancer patients in a single institution
    Su, Jinna
    Liu, Lei
    Xie, Yanli
    Wang, Jianxin
    BMC SURGERY, 2024, 24 (01)
  • [29] Infectious complications of 393 peripherally implantable venous access devices in HIV-positive and HIV-negative patients
    Whigham, CJ
    Goodman, CJ
    Fisher, RC
    Greenbaum, MC
    Thornby, JI
    Thomas, JW
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 1999, 10 (01) : 71 - 77
  • [30] Risk factors for totally implantable venous access device-associated complications in cystic fibrosis
    McCarthy, C.
    O'Carroll, O.
    O'Brien, M. E.
    McEnery, T.
    Franciosi, A.
    Gunaratnam, C.
    McElvaney, N. G.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2018, 187 (02) : 429 - 434